![Bayer Aktiengesellschaft Profile Avatar - Palmy Investing](https://financialmodelingprep.com/image-stock/BAYRY.png)
![Bayer Aktiengesellschaft Profile Avatar - Palmy Investing](https://financialmodelingprep.com/image-stock/BAYRY.png)
Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for car…
Drug Manufacturers - General
DE, Leverkusen [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Bayer Aktiengesellschaft (BAYRY) to it's peer group, including competitors as well as it's industry.
All monetary values in mil. except volume - volume is in thousands.
Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Manufacturers—General Average | - - | - - | - - | 146,529.92 | 31,891.32 | 3,009.59 | 22,193.48 | -2,527.90 | 0.01 | -12.1932 | 52.57 | 0.5917 | 0.0430 | 0.01 | 0.07 | 2.2054 | - - | ||
Maximum | - - | - - | - - | 877,106.00 | 515,874.00 | 44,471.00 | 153,378.00 | 3,847.00 | 0.04 | 76.3636 | 1,087.57 | 1.0000 | 0.2558 | 0.06 | 0.53 | 21.1421 | - - | ||
Minimum | - - | - - | - - | 0.00 | 77.00 | -113.00 | -27,870.00 | -63,834.00 | 0.00 | -335.6404 | -0.21 | 0.0683 | -0.9021 | -0.08 | -0.04 | 0.0000 | - - | ||
Merck & Co., Inc. MRK | 100.20 | 0.14 0.14% | 2,946 vs. 11,160 | 253,469.00 | 15,809.00 | 4,762.00 | 2,229.00 | 56,697.00 | 1.8800 | 17.4190 | 0.0059 | 0.7511 | 0.3012 | 0.1180 | 0.0450 | 0.7284 | 2,529.00 | ||
AstraZeneca PLC AZNCF | 133.40 | 0.00 0.00% | 1 vs. 2 | 206,812.00 | 12,622.00 | 2,179.00 | - - | - - | 1.4000 | - - | - - | 0.7521 | - - | - - | - - | - - | 1,550.00 | ||
Bayer Aktiengesellschaft BAYRY | 4.97 | -0.06 -1.19% | 470 vs. 1,298 | 19,530.00 | 13,765.00 | 2,000.00 | -2,626.00 | 0.00 | 2.0400 | 0.8741 | 0.0000 | 0.6031 | 0.1453 | 0.0562 | 0.0167 | 0.8722 | 3,929.00 | ||
GSK plc GLAXF | 16.92 | 0.00 0.00% | 0 vs. 5 | 69,042.00 | 7,363.00 | 1,046.00 | 376.00 | 7,935.00 | 0.2600 | 15.5725 | 0.0087 | 0.7369 | 0.1421 | 0.0756 | 0.0179 | 0.5737 | 4,080.00 | ||
Gilead Sciences, Inc. GILD | 92.24 | -0.56 -0.60% | 1,377 vs. 6,726 | 114,955.00 | 6,686.00 | -4,170.00 | 2,114.00 | 10,656.00 | -3.3400 | -5.4485 | 0.0109 | 0.7679 | -0.6237 | -0.2378 | -0.0741 | 0.8243 | 1,246.00 | ||
Bristol-Myers Squibb Company BMY | 57.61 | -0.04 -0.07% | 4,007 vs. 11,331 | 116,843.00 | 11,865.00 | -11,911.00 | 2,550.00 | 15,640.00 | -5.8900 | -2.2500 | 0.0113 | 0.7529 | -1.0039 | -0.7223 | -0.1203 | 0.9190 | 2,028.00 |
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.